TCL Archive House Measure Would Eliminate AHRQ, Rescind PCORI, Cut Outcomes Research, And Halt NIH’s Title 42 Hiring Program July 20, 2012
TCL Archive Avastin May Trigger Two FDA Decisions: One On Approval, Another On Withdrawal September 3, 2010